Article Text

Download PDFPDF
Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth
  1. J C S Dean1,
  2. H Hailey1,
  3. S J Moore2,
  4. D J Lloyd3,
  5. P D Turnpenny4,
  6. J Little5
  1. 1Department of Medical Genetics, Medical School, Foresterhill, Aberdeen AB25 2ZD, UK
  2. 2Medical Genetics Program, Memorial University of Newfoundland, St John's, Newfoundland A1B 3V6, Canada
  3. 3Department of Neonatal Medicine, Aberdeen Maternity Hospital, Aberdeen, UK
  4. 4Department of Clinical Genetics, Royal Devon and Exeter Hospital, Barrack Road, Exeter EX2 5DW, UK
  5. 5Epidemiology Group, Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, UK
  1. Correspondence to:
 Dr J C S Dean, Department of Medical Genetics, Medical School, Foresterhill, Aberdeen AB25 2ZD, UK;
 j.dean{at}abdn.ac.uk

Abstract

Objective: To investigate the frequency of neonatal and later childhood morbidity in children exposed to antiepileptic drugs in utero.

Design: Retrospective population based study.

Setting: Population of the Grampian region of Scotland.

Participants: Mothers taking antiepileptic drugs in pregnancy between 1976 and 2000 were ascertained from hospital obstetric records and 149 (58% of those eligible) took part. They had 293 children whose health and neurodevelopment were assessed.

Main outcome measures: Frequencies of neonatal withdrawal, congenital malformations, childhood onset medical problems, developmental delay, and behaviour disorders.

Results: Neonatal withdrawal was seen in 20% of those exposed to antiepileptic drugs. Congenital malformations occurred in 14% of exposed pregnancies, compared with 5% of non-exposed sibs, and developmental delay in 24% of exposed children, compared with 11% of non-exposed sibs. After excluding cases with a family history of developmental delay, 19% of exposed children and 3% of non-exposed sibs had developmental delay, 31% of exposed children had either major malformations or developmental delay, 52% of exposed children had facial dysmorphism compared with 25% of those not exposed, 31% of exposed children had childhood medical problems (13% of non-exposed sibs), and 20% had behaviour disorders (5% of non-exposed).

Conclusion: Prenatal antiepileptic drug exposure in the setting of maternal epilepsy is associated with developmental delay and later childhood morbidity in addition to congenital malformation.

  • epilepsy
  • anticonvulsants
  • malformation
  • neurodevelopment

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

Linked Articles